EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
13.48
+0.28 (2.12%)
Mar 16, 2026, 4:00 PM EDT - Market closed

EyePoint Revenue

In the year 2025, EyePoint had annual revenue of $31.37M, down -27.50%. EyePoint had revenue of $620.00K in the quarter ending December 31, 2025, a decrease of -94.65%.

Revenue (ttm)
$31.37M
Revenue Growth
-27.50%
P/S Ratio
35.82
Revenue / Employee
$146,593
Employees
214
Market Cap
1.13B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202531.37M-11.90M-27.50%
Dec 31, 202443.27M-2.75M-5.97%
Dec 31, 202346.02M4.61M11.14%
Dec 31, 202241.40M4.47M12.09%
Dec 31, 202136.94M2.50M7.27%
Dec 31, 202034.44M14.07M69.10%
Dec 31, 201920.37M15.79M345.53%
Dec 31, 20184.57M1.61M54.37%
Sep 30, 20182.96M--
Jun 30, 20182.96M--
Dec 31, 20172.96M-4.58M-60.72%
Jun 30, 20177.54M--
Dec 31, 20167.54M5.92M365.37%
Jun 30, 20161.62M--
Dec 31, 20151.62M-24.95M-93.90%
Jun 30, 201526.57M23.09M664.90%
Jun 30, 20143.47M1.33M62.06%
Jun 30, 20132.14M-1.38M-39.22%
Jun 30, 20123.53M-1.44M-28.98%
Jun 30, 20114.97M-18.09M-78.46%
Jun 30, 201023.05M10.89M89.55%
Jun 30, 200912.16M8.69M249.88%
Jun 30, 20083.48M1.69M94.73%
Jun 30, 20071.79M749.00K72.30%
Jun 30, 20061.04M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Geron183.88M
Monte Rosa Therapeutics181.54M
AbCellera Biologics75.13M
Septerna45.95M
Inhibrx Biosciences1.40M
Revenue Rankings